Reliability and Validity of a Thai Version of the Edmonton Symptom Assessment Scale (ESAS-Thai)

Chinda, Montarat; Jaturapatporn, Darin; Kirshen, Albert J.; Udomsubpayakul, Umaporn

doi:10.1016/j.jpainsymman.2011.02.020

Cited by 43 publications

(24 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reliability of the ESAS was evaluated by calculating the internal consistency and the test-retest values. The internal consistency values that were calculated were considered adequate and were in accordance with those reported by previous ESAS validation studies [ 9 , 14 , 15 , 38 ]. Regarding test-retest reliability, our results were also considered quite adequate.…”

Section: Discussionsupporting

confidence: 79%

The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients

et al. 2015

View full text Add to dashboard Cite

PurposesTo develop and validate a Portuguese version of the Edmonton Symptom Assessment System (ESAS) in Brazilian patients with advanced cancer.MethodsThe ESAS was translated and then back translated into Portuguese in accordance with international guidelines. The final version was approved by an Expert Committee after pilot testing on 24 advanced cancer patients. Subsequently, we evaluated the time to complete the assessment, the number of unanswered items, internal consistency, convergent validity, and known-group validity in a sample of 249 advanced cancer patients who completed the ESAS along with the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30), Hospital Anxiety and Depression Scale (HADS), and Epworth Sleepiness Scale (ESS). A total of 90 clinically stable patients were retested after 4 to 96 hours (test-retest reliability), and 80 patients answered the ESAS after 21 (±7) days to measure scale responsiveness using an anchor-based method.ResultsThe ESAS was completed in a mean time of only 2.2 minutes. The internal consistency was good (Cronbach's alpha = 0.861), and the removal of single items did not change the overall alpha value. For convergent validity, Spearman’s correlation coefficients between the ESAS symptom scores and the corresponding EORTC QLQ-C30 and ESS symptom scores ranged between 0.520 (95% CI = 0.424–0.605) and 0.814 (95% CI = 0.760–0.856), indicating moderate to strong correlations. Test-retest reliability values were considered adequate, with intraclass correlation coefficients ranging from 0.758 (95% CI = 0.627–0.843) to 0.939 (95% CI = 0.905–0.960).ConclusionsESAS is a feasible, valid and reliable multi-symptom assessment instrument for use in Brazil.

show abstract

Section: Discussionsupporting

confidence: 79%

The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients

et al. 2015

View full text Add to dashboard Cite

show abstract

“…When compared with the Thai ESAS, internal consistency of Thai POS is higher (Cronbach's alpha of the Thai ESAS is 0.75) (12). Additionally, in the assessment of face validity of the Thai ESAS, patients reported that the range of the numerical scale (0 to 10) was too wide for measurement of emotion, and the meaning of each scale point should be explained (12).…”

Section: Discussionmentioning

confidence: 99%

“…To ensure use of outcome measures in the field of palliative care that are consistent, and that reflect the concerns of our patient and family population, we should use existing tools that have sound properties rather than developing new ones (11). The palliative care measures revalidated in Thailand to date (Edmonton Symptom Assessment Schedule (12) and the Palliative Performance Scale (13)) do not cover all important domains in palliative care (14). The Palliative Outcome Scale (POS) is one of the most commonly used tools in research and clinical practice (15).…”

Section: Introductionmentioning

confidence: 99%

Validity, Reliability, and Responsiveness of the Thai Palliative Care Outcome Scale Staff and Patient Versions Among Cancer Patients

Pukrittayakamee

Sapinum

Suwan

et al. 2018

Journal of Pain and Symptom Management

View full text Add to dashboard Cite

show abstract

“…Multiple research groups have further validated ESAS both linguistically and psychometrically in Chinese,(26) Flemish,(27) French,(28) German,(29) Icelandic,(30) Italian,(31), Japanese,(32) Korean,(33) Portugese,(35) Spanish,(34) Thai,(36) and Turkish. (37) An Arabic variation of ESAS is also available.…”

Section: B Past Developmentsmentioning

confidence: 99%

The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments

Hui

Bruera

2017

Journal of Pain and Symptom Management

489

375

View full text Add to dashboard Cite

Context Routine symptom assessment represents the cornerstone of symptom management. ESAS is one of the first quantitative symptom assessment batteries that allows for simple and rapid documentation of multiple patient-reported symptoms at the same time. Objective To discuss the historical development of ESAS, its current uses in different settings, and future developments. Methods Narrative review Results Since its development in 1991, ESAS has been psychometrically validated and translated into over 20 languages. We will discuss the variations, advantages and limitations with ESAS. From the clinical perspective, ESAS is now commonly used for symptom screening and longitudinal monitoring in patients seen by palliative care, oncology, nephrology, and other disciplines in both inpatient and outpatient settings. From the research perspective, ESAS has offered important insights into the nature of symptom trajectory, symptom clusters and symptom modulators. Furthermore, multiple clinical studies have incorporated ESAS as a study outcome and documented the impact of various interventions on symptom burden. On the horizon, multiple groups are actively investigating further refinements to ESAS, such as incorporating it in electronic health records, employing ESAS as a trigger for palliative care referral, and coupling ESAS with personalized symptom goals to optimize symptom response assessment. Conclusion ESAS has evolved over the past 25 years to become an important symptom assessment instrument in both clinical practice and research. Future efforts are needed to standardize this tool and explore its full potential to support symptom management.

show abstract

Reliability and Validity of a Thai Version of the Edmonton Symptom Assessment Scale (ESAS-Thai)

Abstract: After the translation and cross-cultural adaptation, the Thai version of the ESAS achieved good levels of face validity and internal consistency. It is now available as a patient-administered instrument to evaluate symptoms among palliative care patients in Thailand.

Cited by 43 publications

References 12 publications

The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients

The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients

Validity, Reliability, and Responsiveness of the Thai Palliative Care Outcome Scale Staff and Patient Versions Among Cancer Patients

The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments

Contact Info

Product

Resources

About